The effect of infectious dose on humoral and cellular immune responses in Chlamydophila caviae primary ocular infection

Following infection, the balance between protective immunity and immunopathology often depends on the initial infectious load. Several studies have investigated the effect of infectious dose; however, the mechanism by which infectious dose affects disease outcomes and the development of a protective immune response is not known. The aim of this study was to investigate how the infectious dose modulates the local and systemic humoral and the cellular immune responses during primary ocular chlamydial infection in the guinea pig animal model. Guinea pigs were infected by ocular instillation of a Chlamydophila caviae-containing eye solution in the conjunctival sac in three different doses: 1×102, 1×104, and 1×106 inclusion forming units (IFUs). Ocular pathology, chlamydial clearance, local and systemic C. caviae-specific humoral and cellular immune responses were assessed. All inocula of C. caviae significantly enhanced the local production of C. caviae-specific IgA in tears, but only guinea pigs infected with the higher doses showed significant changes in C. caviae-specific IgA levels in vaginal washes and serum. On complete resolution of infection, the low dose of C. caviae did not alter the ratio of CD4+ and CD8+ cells within guinea pigs’ submandibular lymph node (SMLN) lymphocytes while the higher doses increased the percentages of CD4+ and CD8+ cells within the SMLN lymphocytes. A significant negative correlation between pathology intensity and the percentage of CD4+ and CD8+ cells within SMLN lymphocyte pool at selected time points post-infection was recorded for both 1×104, and 1×106 IFU infected guinea pigs. The relevance of the observed dose-dependent differences on the immune response should be further investigated in repeated ocular chlamydial infections.

[1]  B. Arulanandam,et al.  Chlamydial Protease-Like Activity Factor Mediated Protection Against C. trachomatis In Guinea Pigs , 2016, Immunology and cell biology.

[2]  M. Kundi,et al.  Infectious dose and repeated infections are key factors influencing immune response characteristics in guinea pig ocular chlamydial infection. , 2016, Microbes and infection.

[3]  U. Mayr,et al.  Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers , 2015, PloS one.

[4]  M. Starnbach,et al.  Protective Immunity against Chlamydia trachomatis Can Engage Both CD4+ and CD8+ T Cells and Bridge the Respiratory and Genital Mucosae , 2015, The Journal of Immunology.

[5]  B. Arulanandam,et al.  Use of a Guinea Pig-Specific Transcriptome Array for Evaluation of Protective Immunity against Genital Chlamydial Infection following Intranasal Vaccination in Guinea Pigs , 2014, PloS one.

[6]  K. Roskin,et al.  HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria. , 2014, Cell host & microbe.

[7]  H. Caldwell,et al.  CD8+ T Cells Define an Unexpected Role in Live-Attenuated Vaccine Protective Immunity against Chlamydia trachomatis Infection in Macaques , 2014, The Journal of Immunology.

[8]  M. Burton,et al.  Towards a safe and effective chlamydial vaccine: Lessons from the eye , 2014, Vaccine.

[9]  R. Rank,et al.  Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. , 2013, Pathogens and disease.

[10]  M. Dagleish,et al.  Intranasal Infection with Chlamydia abortus Induces Dose-Dependent Latency and Abortion in Sheep , 2013, PloS one.

[11]  J. Slaven,et al.  Plac8-Dependent and Inducible NO Synthase-Dependent Mechanisms Clear Chlamydia muridarum Infections from the Genital Tract , 2012, The Journal of Immunology.

[12]  M. Rothe,et al.  A Bovine Model of Respiratory Chlamydia psittaci Infection: Challenge Dose Titration , 2012, PloS one.

[13]  H. Weiss,et al.  Active Trachoma Is Associated with Increased Conjunctival Expression of IL17A and Profibrotic Cytokines , 2011, Infection and Immunity.

[14]  M. D. de Jonge,et al.  A novel guinea pig model of Chlamydia trachomatis genital tract infection. , 2011, Vaccine.

[15]  R. Rank,et al.  Essential Role for Neutrophils in Pathogenesis and Adaptive Immunity in Chlamydia caviae Ocular Infections , 2011, Infection and Immunity.

[16]  T. Phillips,et al.  M cell-targeted ocular immunization: effect on immunoglobulins in tears, feces, and serum. , 2010, Investigative ophthalmology & visual science.

[17]  David P. Wilson,et al.  Ocular pathologic response elicited by Chlamydia organisms and the predictive value of quantitative modeling. , 2009, The Journal of infectious diseases.

[18]  G. Myers,et al.  Strain and Virulence Diversity in the Mouse Pathogen Chlamydia muridarum , 2009, Infection and Immunity.

[19]  P. Timms,et al.  Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice , 2009, Immunology and cell biology.

[20]  J. Whittimore,et al.  Chlamydiae and polymorphonuclear leukocytes: unlikely allies in the spread of chlamydial infection. , 2008, FEMS immunology and medical microbiology.

[21]  H. Taylor Trachoma: A Blinding Scourge from the Bronze Age to the Twenty-first Century , 2008 .

[22]  M. Starnbach,et al.  Immune‐mediated control of Chlamydia infection , 2007, Cellular microbiology.

[23]  H. Dockrell,et al.  The Frequency of Chlamydia trachomatis Major Outer Membrane Protein-Specific CD8+ T Lymphocytes in Active Trachoma Is Associated with Current Ocular Infection , 2006, Infection and Immunity.

[24]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[25]  M. Burton,et al.  Cytokine and Fibrogenic Gene Expression in the Conjunctivas of Subjects from a Gambian Community Where Trachoma Is Endemic , 2004, Infection and Immunity.

[26]  K. Kelly,et al.  The Infecting Dose of Chlamydia muridarum Modulates the Innate Immune Response and Ascending Infection , 2004, Infection and Immunity.

[27]  R. Rank,et al.  Characterization of Chlamydial Genital Infection Resulting from Sexual Transmission from Male to Female Guinea Pigs and Determination of Infectious Dose , 2003, Infection and Immunity.

[28]  H. Wigzell,et al.  The role of IFN-γ in the outcome of chlamydial infection , 2002 .

[29]  H. Whittle,et al.  Failure to detect HLA‐A*6802‐restricted CD8+ T cells specific for Chlamydia trachomatis antigens in subjects from trachoma‐endemic communities , 2001, Clinical and experimental immunology.

[30]  H. Caldwell,et al.  Immunity to Murine Chlamydia trachomatis Genital Tract Reinfection Involves B Cells and CD4+ T Cells but Not CD8+ T Cells , 2000, Infection and Immunity.

[31]  H. Caldwell,et al.  Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. , 1999, Journal of immunology.

[32]  H. Brade,et al.  Characterization of a Neutralizing Monoclonal Antibody Directed at the Lipopolysaccharide of Chlamydia pneumoniae , 1998, Infection and Immunity.

[33]  D. Conway,et al.  Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma‐endemic population , 1997, Clinical and experimental immunology.

[34]  D. Conway,et al.  T helper type‐1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring , 1996, Clinical and experimental immunology.

[35]  R. Morrison,et al.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection , 1995, Infection and immunity.

[36]  J. Whittum-Hudson,et al.  Murine model of ocular infection by a human biovar of Chlamydia trachomatis. , 1995, Investigative ophthalmology & visual science.

[37]  R. Rank,et al.  Role of CD8 T cells in primary Chlamydia infection , 1995, Infection and immunity.

[38]  R. Rank,et al.  Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. , 1993, Regional immunology.

[39]  T. Fielder,et al.  Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies , 1991, Infection and immunity.

[40]  H. Caldwell,et al.  Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants , 1989, Infection and immunity.

[41]  R. Peeling,et al.  Complement enhancement of neutralizing antibody to the structural proteins of Chlamydia trachomatis. , 1988, The Journal of infectious diseases.

[42]  R. Rank,et al.  Susceptibility to reinfection after a primary chlamydial genital infection , 1988, Infection and immunity.

[43]  R. Rank,et al.  Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection , 1988, Infection and immunity.

[44]  D. Levitt,et al.  Patterns of immunoenhancement and suppression induced by Chlamydia trachomatis in vivo and in vitro. , 1988, Journal of immunology.

[45]  H. Caldwell,et al.  Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. , 1987, Journal of immunology.

[46]  E. Young,et al.  Immune mechanisms in chlamydial eye infection: cellular immune responses in chronic and acute disease. , 1984, The Journal of infectious diseases.

[47]  K. Holmes,et al.  Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix , 1983, Infection and immunity.

[48]  R. Rank,et al.  Humoral Immune Response in Acquired Immunity to Chlamydial Genital Infection of Female Guinea Pigs , 1983, Infection and immunity.

[49]  J. Schachter,et al.  Serum and tear antibodies to Chlamydia after reinfection with guinea pig inclusion conjunctivitis agent. , 1981, Investigative ophthalmology & visual science.

[50]  M. Monnickendam,et al.  Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea-pigs. , 1980, The British journal of ophthalmology.

[51]  M. Monnickendam,et al.  Guinea-pig inclusion conjunctivitis as a model for the study of trachoma: clinical, microbiological, serological, and cytological studies of primary infection. , 1980, The British journal of ophthalmology.

[52]  R. Rank,et al.  Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis , 1979, Infection and immunity.

[53]  K. Pedersen The origin of immunoglobulin-G in bovine tears. , 1973, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[54]  E. S. Murray,et al.  Immunologic studies in guinea pigs with guinea pig inclusion conjunctivitis (GP-IC) Bedsonia. , 1967, American journal of ophthalmology.

[55]  E. S. Murray GUINEA PIG INCLUSION CONJUNCTIVITIS VIRUS. I. ISOLATION AND IDENTIFICATION AS A MEMBER OF THE PSITTACOSIS-LYMPHOGRANULOMA-TRACHOMA GROUP. , 1964, The Journal of infectious diseases.

[56]  F. Haesebrouck,et al.  Mucosal and systemic humoral immune response of turkeys after infection and reinfection with a Chlamydia psittaci serovar D strain. , 1998, Avian diseases.

[57]  J. Whittum-Hudson,et al.  Animal models for ocular infections. , 1994, Methods in enzymology.

[58]  J. Whittum-Hudson,et al.  Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. , 1986, Investigative ophthalmology & visual science.